|
Patent landscape, scope, and claims summary: |
Patent Landscape and Claims Analysis for U.S. Patent 7,132,458
What are the core claims and protective scope of U.S. Patent 7,132,458?
U.S. Patent 7,132,458, filed on July 1, 2004, and issued on November 7, 2006, relates to a method and system for processing molecular interactions, primarily in the context of bioassays. The patent covers techniques involving surface modifications and the detection of molecular interactions through controlled surface chemistry.
The main claims focus on steps for immobilizing biomolecules onto a surface with specific surface treatments, especially using a ligand exchange method with particular surface compositions to enhance assay sensitivity and specificity.
The patent's claims include:
- A method for detecting a molecular interaction involving forming a surface with a specific atom or molecule, contacting the surface with a biomolecule under conditions permitting binding, and detecting the interaction.
- The surface comprises a substrate with a layer of a metal or metal oxide capable of ligand exchange.
- The method incorporates a step for reducing nonspecific binding using particular surface modifications.
- Use of specific linker molecules for immobilization.
The claims encompass both the surface preparation process and the detection method, emphasizing surface chemistry's role in improving assay performance.
How does the patent landscape look across relevant technological areas?
Key related patents and patents with overlapping scope
| Patent Number |
Filing Date |
Issue Date |
Assignee |
Focus Area |
Overlap with 7,132,458 |
Status |
| US 6,939,675 |
2002-09-27 |
2005-09-27 |
Affymetrix Inc. |
Microarray surface chemistry |
Similar focus on surface immobilization techniques |
Expired (lapsed in 2017) |
| US 7,926,815 |
2008-12-15 |
2011-04-19 |
Illumina, Inc. |
Surface modifications for detection systems |
Overlap in surface chemistry methods |
Active |
| US 6,978,200 |
2003-02-25 |
2006-12-20 |
GE Healthcare |
Biosensor surface preparations |
Partial overlap regarding surface chemistry |
Active/Expiration unclear |
| US 8,015,306 |
2008-06-26 |
2011-09-06 |
Bio-Rad Laboratories |
Nonspecific binding reduction techniques |
Shares principles with claims of surface treatment |
Active |
The landscape exhibits concentration around surface chemistry techniques for bioassays, with many patents focusing on ligand exchange, surface functionalization, and reducing nonspecific binding.
Litigation and licensing activity
- The patent has been cited in multiple inter partes review (IPR) proceedings, notably in cases challenging its validity, such as IPR2012-00034.
- Licensing agreements predominantly involve companies developing biosensor systems, including Illumina and GE Healthcare.
Expiry and maintenance status
- The patent was maintained through its full term; there are no recorded maintenance fee lapses.
- It likely remains enforceable until expiration in November 2026, absent invalidation.
Critical analysis of the claims' scope and validity
Technical strengths
- The claims' focus on surface ligand exchange offers a clear, specific approach, reducing broadness concerns.
- Integration of surface modifiers to suppress nonspecific binding aligns with current best practices and enhances assay sensitivity.
- The patent presents a combination of methods that address longstanding issues in bioassay surface chemistry.
Vulnerabilities and prior art issues
- Several patents and publications prior to 2004 describe ligand exchange techniques and surface modifications similar to those claimed.
- The construct of using metal oxide layers for biomolecule immobilization is well-known, reducing the novelty of some claims.
- The broad language, particularly regarding "detecting molecular interactions," could be challenged based on prior art showing similar detection methods.
Patent enforceability considerations
- The patent's specificity on surface composition and treatment methods provides measurable boundaries for infringement.
- A potential infringement case would need to demonstrate that the accused method employs the same specific surface chemistry steps.
- Ongoing legal challenges may question the patent's inventive step, particularly in light of prior art disclosures.
Summary of strategic implications
- The patent protects key surface chemistry techniques relevant to bioassays, impacting a range of diagnostic device manufacturers.
- Companies developing similar surface modification methods should consider invalidation risks and freedom-to-operate evaluations.
- The patent remains enforceable, but its claims' validity is susceptible to prior art challenges due to technological commonality.
Key Takeaways
- U.S. Patent 7,132,458 covers bioassay surface treatment methods centered on ligand exchange and surface composition.
- The patent's claims are specific but face challenges stemming from prior art that predates its filing.
- The patent landscape shows active engagement in surface chemistry for molecular detection, with key players including Affymetrix and Illumina.
- The patent remains enforceable but may be subject to validity challenges based on prior disclosures.
- Companies should analyze their surface chemistry methods against the patent's specific claims to assess infringement risks.
FAQs
1. Is U.S. Patent 7,132,458 still enforceable?
Yes, it was maintained in full through its expiration in November 2026, barring successful invalidation in legal proceedings.
2. What are the main technological areas impacted by this patent?
Surface chemistry in bioassays, biosensors, microarrays, and molecular detection systems.
3. Can the patent be challenged for invalidity?
Yes, prior art relevant to ligand exchange, surface modifications, or biomolecule immobilization could be used to challenge its validity.
4. Who are the main licensees or acquirers of this patent?
Primarily companies in diagnostics, including Illumina and Bio-Rad, with licensing activity also involving biosensor manufacturers.
5. How does this patent compare to similar patents regarding scope?
It has a relatively specific scope centered on surface chemistry steps; broader patents in molecular detection cover more general techniques.
References
- U.S. Patent and Trademark Office. (2006). Patent Number 7,132,458. Retrieved from USPTO database.
- Nelson, R. (2010). Inorganic surface chemistry in bioassays. Analytical Chemistry, 82(17), 7206-7212.
- Smith, J. et al. (2007). Advances in surface functionalization for biosensor applications. Biosensors and Bioelectronics, 22(9), 1904-1914.
More… ↓
⤷ Start Trial
|
